Illumina's most recent trend suggests a bullish bias. One trading opportunity on Illumina is a Bull Put Spread using a strike $130.00 short put and a strike $120.00 long put offers a potential 6.95% return on risk over the next 11 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $130.00 by expiration. The full premium credit of $0.65 would be kept by the premium seller. The risk of $9.35 would be incurred if the stock dropped below the $120.00 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Illumina is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Illumina is bullish.
The RSI indicator is at 57.69 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Illumina
Valeant, Tesla Working On Bases As Energy Dominates
Mon, 05 May 2014 22:34:00 GMT
Illumina to Webcast Live Presentation at Upcoming Investment Conferences in May and June
Mon, 05 May 2014 10:30:00 GMT
Business Wire – Illumina, Inc. today announced that it will webcast the Company’s presentation at three upcoming investment conferences.
Illumina Launches VeriSeq PGS
Tue, 29 Apr 2014 10:30:00 GMT
Business Wire – Illumina, Inc. today announced the launch of VeriSeqTM PGS, a next-generation sequencing solution developed for preimplantation genetic screening of embryos using Illumina’s NextSeqTM 500 and MiSeq® sequencing systems.
Pricing Power for Novel Biotech Drug Therapies Despite Obamacare: A Wall Street Transcript Interview with Boris Peaker, Ph.D., Executive Director and Senior Analyst with Oppenheimer & Co. Covering the Biotechnology Sector
Mon, 28 Apr 2014 17:12:00 GMT
Illumina Files New Patent Infringement Suit Against Ariosa Diagnostics, Inc.
Fri, 25 Apr 2014 20:05:00 GMT
Business Wire – Illumina announced today that the company has filed a new patent infringement suit against Ariosa Diagnostics, Inc. Illumina is seeking all available remedies, includ
Also on Market Tamer…
Follow Us on Facebook